Penn researchers want to know how opioids affect brain development via neuroimaging

Researchers from the University of Pennsylvania are working to develop a new MRI technique to better understand how opioid exposure impacts the brain development of young children.

Thanks to a $550,000 grant from the National Institutes of Health’s Helping to End Addiction Long-term (NIH HEAL) project, a pair of Penn researchers will scan 100 awake 3-5 year old children, comparing the quality of traditional MRI methods to those taken using a motion-correction technology. The latter, used in other NIH research, is particularly helpful when trying to image restless children, Dylan Tisdall, a researcher on the project, said in a Penn Today news story.

The study—currently in phase I—is part of a larger NIH initiative called the HEALthy Brain and Child Development Study, which has been following 10,000 children, many exposed to opioids before birth, from the day they were born until their 10th birthday.

“We’re excited to be able to bring in 100 kids, to try out these new technologies and potentially get new data,” Tisdall told Penn Today. “Hopefully, we can start to get some preliminary answers to the big scientific questions.”

Read the entire story below:

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.